Peptides
Thymalin
Also called Thymalin
Thymalin is considered for immune support, recovery after illness and healthy aging. It is a thymus-derived peptide mixture, so it is not interchangeable with thymosin alpha-1 or every vial sold under a similar name. A short hospital treatment study is more concrete than broad claims of an immune “reset” or longer life.
Dosage & duration
Published hospital study · thymus-extract product
Severe COVID-19 adjunct study
Published example · product-specific- Dose
- 10 mg per injection
- How often
- Once daily, intramuscular
- How long
- 10 days
Given with then-standard hospital care. Not an at-home infection treatment or validated longevity cycle.
Sources: 1
An extract’s milligram amount cannot be transferred to a different synthetic peptide sold under a similar name.
Why people consider Thymalin
Recovering well and staying well
-
Fewer illnesses
People hope to get sick less often; the reviewed hospital study does not establish routine prevention.
-
Recovery after illness
Better day-to-day function matters, but results in seriously ill patients may not transfer to wellness use.
-
Healthy aging
A changed immune-cell count does not establish a longer life or an immune “reset”.
Why do people look at Thymalin?
The promise is help with immune resilience rather than muscle growth or immediate stimulation. Short courses and healthy-aging claims make it appealing, but a useful outcome would be fewer infections or better function—not simply a shift in an immune-cell test.
What does the published course mean?
The visible example comes from a small hospitalized severe-COVID-19 study. It gives a real amount, route and duration without pretending those patients represent wellness users. It does not establish routine prevention, a repeat interval or replacement of current care.
The name on the vial matters
The studied Thymalin preparation was a thymus-derived mixture. Thymulin and thymosin alpha-1 are different substances. A seller’s similar name, amino-acid claim or vial size does not establish equivalence to the original preparation.
Can it reset an aging immune system?
That phrase promises more than the reviewed evidence establishes. There is no simple consumer measurement of an immune reset, and a relative timing plot cannot supply one. Persistent infections or unexplained slow recovery should prompt assessment of their cause.
Model details: Thymalin · relative timing
Compare timing and buildup for this compound. The values are not blood concentrations or a measure of strength.
Shows a relative timing scenario; absolute blood concentrations are not calibrated.
Timing assumptions and sources
Legacy 0.96 h is an assumed single-timescale approximation, not measured clearance of the extract.
One 1 mg input peaks at 1 relative unit after a single dose. Other amounts scale proportionally; overlapping doses add when accumulation is on. Different compounds use separate relative scales.
- Timing half-life used
- 0.96 hours
- Absorption half-life assumed
- 0.24 hours
- Reference amount for the relative scale
- 1 mg
- Absorption half-life is assumed to be one quarter of the slower timescale (0.24 h); it is not a measured absorption parameter.
- A single 1-unit input has a peak of 1 relative unit; scaling and repeated-dose addition are mathematical assumptions. This normalization is independent of the example dose.
- Do not transfer thymosin alpha 1, thymogen or vilon PK to this mixture.
- Total preparation mass does not identify a circulating peptide analyte.
- Peptide Drug Thymalin Regulates Immune Status in Severe COVID-19 Older Patients
Legacy 0.96 h is an assumed single-timescale approximation, not measured clearance of the extract.
- Peptide Drug Thymalin Regulates Immune Status in Severe COVID-19 Older Patients
IM thymus-derived peptide complex; clinical immune/outcome observations do not measure parent-drugPK.
thymalin-relative-timing-2026-10 · version 1
Common questions
Is Thymalin the same as thymosin alpha-1?
No. They are different preparations; their study doses and courses should not be swapped.
Does ten days establish a yearly longevity cycle?
No. It describes one hospital study, not evidence for periodic use by healthy adults.
Sources Labels, studies and notes behind this guide
Catalog evidence: Other human research. This describes the type of evidence, not a clinical review of every claim.
Summary and fact source checks: 2026-10-07. This records source checking, not medical review of the whole page.
Notes on the quick facts
- Main interest
- Fewer illnesses and better recovery are goals, not established effects in healthy users.
- Course in research
- The hospital study is not an annual anti-aging schedule.
- Check the product
- Thymalin, thymulin and thymosin alpha-1 are not interchangeable names.
- 1. Thymalin severe-COVID-19 study
Full original study inspected: 80 hospitalized adults; 36 received 10 mg IM daily for 10 days alongside standard treatment; single-center study, not wellness prevention.
- 2. Thymalin translated product instruction
Supplier-hosted instruction search text: animal-thymus extract, 10 mg IM preparation. Used for formulation distinction, not proof every research vial matches it.
- 3. Peptide Drug Thymalin Regulates Immune Status in Severe COVID-19 Older Patients
Legacy 0.96 h is an assumed single-timescale approximation, not measured clearance of the extract.
- 4. Thymalin and human hematopoietic stem-cell differentiation
Original laboratory study of an animal-thymus polypeptide complex and cell markers; not a human treatment trial or PK characterization.
Related compounds and examples
Related compounds
Thymosin Alpha-1
Thymosin Alpha-1: immune-support claims, Zadaxin doses and why the illness being treated matters.
LL-37 (Cathelicidin)
LL-37 for immune, gut and wound-healing questions: what people seek, reported injection amounts and what topical human trials actually found.
KPV
KPV for gut and skin concerns: oral versus injected products, reported dose context and realistic expectations for inflammation claims.